Earth Science Tech, Inc. Expands Marketing Campaign to MassRoots (OTC: MSRT), Natural Awakenings Magazine, and Enhances Product Packaging

| Source: Earth Science Tech, Inc. Earth Science Tech, Inc.

Hollywood, March 30, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST" or "the Company"), an innovative biotech company focused on cannabis (industrial hemp) and cannabinoid research and development, nutraceuticals, pharmaceuticals, and medical devices, has been working closely with different advertising outlets to continue increasing demand for Earth Science Tech’s products across the country.

In April, Earth Science Tech will be featured in a half-page ad in Natural Awakenings magazine, a publishing outlet that reaches 4+ million consumers across the entire U.S., and several other countries. Additionally, the company’s advertising statistics show that 80% of their readers make purchases based on advertisements they see in Natural Awakenings. (http://www.naturalawakeningsmag.com)

“Natural Awakenings has historically had very high ROI opportunities for its advertisers,” said CSO and Director, Gabriel Aviles, “They reach a demographic that has disposable income, is passionate about health, and seeks natural alternatives. This is a great market for us to tell our story to.”

Also in April, the company will be working with MassRoots (OTC: MSRT) to build demand for our new product lines launching within Q2 2017. MassRoots is one of the largest web portals within the cannabis industry, and over 1,000,000 cannabis enthusiasts are registered with the platform. This is one of the best niche advertising locations for a cannabis-based product to reach. (https://massroots.com)

“MassRoots is hands down one of the best platforms to launch a cannabis-based (Indsutrial Hemp) product from,” said CMO Sergio Castillo, “We can reach nearly a million registered users, gain major brand recognition, and build early demand for our innovative new products. This is a great opportunity for maximum brand exposure.”

In order for our current and new product lines to appeal to a wider range of customers, the packaging is being revamped and will now feature UV spotting on the front/face of the boxes. The relaxing amber bottles will now reflect the company’s blue and white branding with its new packaging.

“Our new packaging's sleek, modern, and attractive appearance will capture new and existing consumers differentiating our brand from competitors,” said President, Director, and COO, Nickolas Tabraue, “We’ve stayed true to our branding, but our new look stands to set us apart from the competition on the shelves. We are very happy with how our packaging is turning out and we are looking forward to very promosing Q2 2017 launch.”

ETST will continuously update its shareholders on the new packaging, new products be launched during Q2, joint ventures being finalized, and other developments as further progress occurs.

About Earth Science Tech, Inc. (ETST): Earth Science Tech is a publicly traded (ETST) unique Science based Biotechnology company focused on cutting edge Nutraceuticals, Bioceuticals, Phytoceuticals, Pharmaceuticals, and Medical devises for the Health, Wellness and Alternative Medicine Markets to help improve the quality of life for Consumers Worldwide. Visit corporate website at www.earthsciencetech.com

ETST is focused on researching and developing innovative Hemp extracts and to make them accessible Worldwide. ETST plans to be the premier supplier of the highest quality and purity of High Grade Hemp CBD (Cannabidiol) Oil. ETST's primary goal is to advance different High Quality Hemp extracts with a broad profile of Cannabinoids and additional natural molecules found in Industrial Hemp and to identify their distinct properties. The company is dedicated in offering its consumers the finest and purest quality All Natural-Organic Hemp CBD Oil while never compromising on quality. Cannabinoids (Cannabidiol/CBD) are natural constituents of the Hemp plant and CBD is derived from Hemp stalk and seed. Hemp oil is a well-known dietary supplement and the naturally occurring CBD possesses no psychoactive qualities and presents a continuing stream of overwhelming evidence of significant Wellness benefits. With no psychoactive ingredient, Hemp CBD Oil is a ready-for-market Hemp-based Nutraceutical. The United States Food and Drug Administration (FDA) currently considers non-THC hemp based cannabinoids, including CBD, to be "food based" and therefore saleable. These new non-psychoactive CBD-rich hemp oil products that ETST has geared up to market and distribute are beyond reproach. CBD (cannabidiol), a naturally occurring constituent of the Industrial Hemp plant, promotes and supports the nutritional health of aging bodies in particular. Source: US Government Patent #6,630,507 "Cannabinoids as antioxidants and neuroprotectants." ETST does not grow, sell or distribute any substances that violate United States Law or the controlled substance act. ETST does sell and distribute cannabis industrial hemp based products.

Some of ETST accomplishments and reports on its High-Grade CBD Hemp Oil include:


About Earth Science Pharmaceutical: Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc (ETST). Earth Science Pharmaceutical is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for STIs (Sexually Transmitted Infections and/or Diseases). Earth Science Pharmaceutical CEO, Dr. Michel Aubé, a renowned scientist, is committed to help grow ETST in the medical and pharmaceutical industry. The company is currently working on finishing the launch of its new corporate website at www.Earthsciencepharmaceutical.com

The accuracy of the MSN-2 medical device for the diagnosis of women with Chlamydia has already been proven via a study of 510 female patients, which showed PCR testing results on paired samples to be identical for 493 (96.6%) of the 510 women. To view this study, visit Evaluation of a Modified Sanitary Napkin as a Sample Self-Collection Device for the Detection of Genital Chlamydial Infection in Women.

About Cannabis Therapeutics: Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc (ETST). Cannabis Therapeutics, Inc. was formed as an emerging biotechnology company poised to become a world leader in cannabinoid research and development for a broad line of cannabis cannabinoid-based pharmaceuticals, nutraceuticals as well as other products & solutions. Cannabis Therapeutics mission it to help change the healthcare landscape by introducing their proprietary cannabis-cannabinoid based products made for both the pharmaceutical and retail consumer markets worldwide. The company is currently working on finishing the launch of its new corporate website at www.Cannabisthera.com 

Some of the R&D that Cannabis Therapeutics will target will be treatments for the conditions and disorders of: Pain, Chronic Pain, PTSD, Breast Cancer, Brain Cancer, Anxiety, Depression, Glaucoma, Crohn’s disease, Fatty Liver Diseases, Diabetes, Parkinson' s Disease, Alzheimer's Disease, Attention Deficit Hyperactivity Disorder (ADHD), and Drug Addictions among other things. ETST has chosen to target diseases for which, the benefits of Cannabinoids and/or CBD (Cannabidiol) have already been demonstrated by different groups of researchers around the world. However, it is through ETST’s in vitro study with the University of Central Oklahoma and DV Biologics that results confirm the positive effectiveness of Earth Science Tech’s CBD (Canabidiol) on breast cancer, immune cell function, and human brain cells by acting as a neuroprotectant as shown in its International Application (PCT) for its Provisional Patent. Thus, as a result by mixing natural molecules and generic pharmaceutical drugs with Cannabinoids and/or CBD (Cannabidiol) we intend to increase the effectiveness of Cannabinoids and/or CBD (Cannabidiol) and improve the treatment of different diseases. The 3 cannabis cannabinoid-based nutraceutcial patents and 2 generic pharmaceutical drugs will be based on ETST’s International Application (PCT) for its Provisional Patent named “Cannabidiol Compositions Including Mixtures and Uses Thereof” was filed on October 8th, 2015 in regards to its Cannabis Hemp CBD (Cannabidiol) Oil. This application claims the benefit of ETST U.S. Provisional Application N. 62/061,577, filed October 8, 2014 and ETST U.S. Provisional Application No. 62/102,538, filed January 12, 2015.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE: These statements and products have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. Always check with your physician before starting a new dietary supplement program. The FDA has not evaluated the validity or truthfulness of these claims; therefore, we encourage you to review published researches relating to the benefits and properties of CBD hemp oils and other CBD products.

SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.


            




    

        

            
                April's Natural Awakening Half Page Ad
                        

                
            

        

    





        

            

                

                    
Mot-clé

                            
                                marketing
                            
                            
                                CBD
                            
                            
                                hemp
                            
                            
                                cannabis
                            
                            
                                cannabidiol
                            
                            
                                magazine
                            
                            
                                ad
                            
                            
                                advertising
                            
                            
                                advertisement
                            
                            
                                industrial hemp
                            
                            
                                branding
                            
                            
                                biotech
                            
                            
                                awarness
                            
                            
                                cannabinoids
                            

                



        




    

        

        
Coordonnées